Dr. Shana Eighan , RPH, PharmD
Pharmacist • Centralia, WA
1800 Cooks Hill Rd Ste B
Centralia, WA 985319162
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 9, 2016; this date does not establish years in practice.
-
Published CMS data list 618 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Methotrexate (Methotrexate Sodium) — 78 prescription fills, including refills.
- Stelara (Ustekinumab) — 70 prescription fills, including refills.
- Kesimpta Pen (Ofatumumab) — 65 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 22 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Part D prescriptions than 95% of clinicians listed under Pharmacist in Washington (2024, 2,129 clinicians with data). Median for this group: 80. Middle half: 43 to 133.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 481 in 2020 to 618 in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020–2024.
Practice Location & Contact Primary Location
1800 Cooks Hill Rd Ste B
Centralia, WA 985319162
What Public CMS Data Show
Pharmacist: NPPES taxonomy is a reported classification, not proof of board certification.
30-day fills
863 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$4,998,030 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Centralia and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
More Part D prescriptions than 95% of clinicians listed under Pharmacist in Washington (2024, 2,129 clinicians with data). Median for this group: 80. Middle half: 43 to 133.
Too few clinicians listed under Pharmacist in Centralia have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 95% of clinicians listed under Pharmacist in Washington (2024, 2,129 clinicians with data). Median for this group: $15,079. Middle half: $7,548 to $26,116.
Too few clinicians listed under Pharmacist in Centralia have Medicare Part D data for 2024 to compare.
38 active clinicians are listed under Pharmacist with a practice address in Centralia, WA (7,786 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Centralia
0% of these 38 clinicians have the CMS telehealth indicator.
0% of these 38 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 28% from 481 in 2020 to 618 in 2024.
- 2020: 481
- 2021: 307
- 2022: 205
- 2023: 306
- 2024: 618
-
30-day fills
30-day fills decreased 23% from 1,125 in 2020 to 863 in 2024.
- 2020: 1,125
- 2021: 511
- 2022: 239
- 2023: 395
- 2024: 863
-
Part D drug cost
Part D drug cost increased 893% from $503,516 in 2020 to $4,998,030 in 2024.
- 2020: $503,516
- 2021: $1,838,114
- 2022: $1,823,926
- 2023: $1,997,509
- 2024: $4,998,030
Sources: CMS Medicare Part D Prescribers (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Methotrexate | Methotrexate Sodium | 78 | 5,767 | $2,057.83 | 54 |
| Stelara | Ustekinumab | 70 | 2,724 | $1,917,355.65 | 12 |
| Kesimpta Pen | Ofatumumab | 65 | 1,920 | $667,287.68 | 15 |
| Copaxone | Glatiramer Acetate | 37 | 1,054 | $220,649.04 | — |
| Humira(Cf) Pen | Adalimumab | 37 | 1,120 | $417,178.18 | 15 |
| Dimethyl Fumarate | Dimethyl Fumarate | 34 | 1,020 | $14,996.16 | — |
| Orencia Clickject | Abatacept | 30 | 1,120 | $225,620.37 | 14 |
| Fingolimod | Fingolimod Hcl | 28 | 840 | $10,949.49 | — |
| Enbrel Sureclick | Etanercept | 25 | 756 | $190,348.09 | — |
| Mayzent | Siponimod | 25 | 750 | $255,711.36 | — |
| Eliquis | Apixaban | 23 | 1,260 | $24,897.81 | — |
| Warfarin Sodium | Warfarin Sodium | 21 | 939 | $157.84 | — |
| Skyrizi On-Body | Risankizumab-Rzaa | 20 | 1,120 | $438,052.99 | — |
| Folic Acid | Folic Acid | 18 | 1,353 | $134.41 | 13 |
| Xeljanz | Tofacitinib Citrate | 15 | 450 | $87,788.11 | — |
| Rebif Rebidose | Interferon Beta-1a/Albumin | 15 | 420 | $162,242.13 | — |
| Teriflunomide | Teriflunomide | 15 | 630 | $32,705.41 | — |
| Kevzara | Sarilumab | 13 | 588 | $87,952.55 | — |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 13 | 13 | $2,640.52 | 13 |
| Otezla | Apremilast | 12 | 358 | $60,182.64 | — |
| Humira Pen | Adalimumab | 12 | 336 | $81,129.40 | — |
| Zeposia | Ozanimod Hydrochloride | 12 | 358 | $97,992.59 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2025-10-15NUCC Taxonomy Code: 183500000X
An individual licensed by the appropriate state regulatory agency to engage in the practice of pharmacy. The practice of pharmacy includes, but is not limited to, assessment, interpretation, evaluation, and implementation, initiation, monitoring or modification of medication and or medical orders; the compounding or dispensing of medication and or medical orders; participation in drug and device procurement, storage, and selection; drug administration; drug regimen reviews; drug or drug-related research; provision of patient education and the provision of those acts or services necessary to provide medication therapy management services in all areas of patient care.
NUCC Taxonomy Code: 183500000X
An individual licensed by the appropriate state regulatory agency to engage in the practice of pharmacy. The practice of pharmacy includes, but is not limited to, assessment, interpretation, evaluation, and implementation, initiation, monitoring or modification of medication and or medical orders; the compounding or dispensing of medication and or medical orders; participation in drug and device procurement, storage, and selection; drug administration; drug regimen reviews; drug or drug-related research; provision of patient education and the provision of those acts or services necessary to provide medication therapy management services in all areas of patient care.
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Pharmacist - Ambulatory Care
Doctor of Pharmacy (Pharm.D.)
Pharmacist
Pharmacist
Pharmacist
Pharmacist - Ambulatory Care
Doctor of Pharmacy (Pharm.D.)
Pharmacist
Doctor of Pharmacy (Pharm.D.)
Pharmacist
Doctor of Pharmacy (Pharm.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1800 COOKS HILL RD STE B, CENTRALIA, WA 985319162 (Tel: 3608276616)
Registered at 1800 COOKS HILL RD STE B, CENTRALIA, WA 985319162 (Tel: 3608276616)
NPI status registered as active in NPPES database
Registered at 1900 NE 3RD ST STE 1111, BEND, OR 977013894 (Tel: 5413891717)
Registered at 67225 HIGHWAY 20, BEND, OR 977039203
Recorded as SHANA EIGHAN, RPH, PHARMD
Pharmacist (license number reported to NPPES: OR RPH-0015558)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Pharmacists in Centralia
All Pharmacists in CentraliaMailing Address
1800 Cooks Hill Rd Ste B
Centralia, WA 985319162
Phone: 3608276616